IN THE NEWS

TipRanks: Innocan Pharma Achieves Key Milestones in 2024

Innocan Pharma gibt vielversprechende Ergebnisse einer Studie an Minischweinen zur Beurteilung der Sicherheit von LPT-CBD bekannt

TipRanks: Innocan Pharma Reports Positive Safety Results

Benzinga: Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth

MSN: Solving chronic pain in dogs – A significant market opportunity

Pat Age: Innocan to Focus on Liposome Platform Technology-CBD Following FDA Engagement

Financial Times: Innocan Pharma Reports Third Quarter 2024 Financial Results with 2.7X Revenue Growth YoY

Investor’s Corner: Solving chronic pain in dogs – A significant market opportunity

InnoCan Pharma Leads 3 Promising Penny Stocks On TSX

The Watchlist: Innocan Pharma's LPT-CBD Shows Long-Term Success

Investing in Pain Relief: Breakthrough Potential for Injectable Liposomal CBD

Innocan Pharma Reports Clinical Success in Canine Compassionate Care Trial

Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

Innocan Pharma Announces the Addition of Dr. Joseph V. Pergolizzi, Jr., M.D. to its Advisory Board

nocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights

Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million

Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.

Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations

Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark

Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs

Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting

Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center

InnoCan Pharma Advances Veterinary CBD Drug with FDA Nod

Canadian Securities Exchange Magazine • November 2022

5 Potentially Undervalued Pharma Companies

Professor Chezy Barenholz On a CBD-Powered Revolution in Pharmaceuticals

InnoCan Pharma Reports Impressive Preclinical Trial Results as it Eyes Expansion into $52b Veterinary Services Industry

A Case Report of Subcutaneously Injected Liposomal Cannabidiol Formulation Used as a Compassion Therapy for Pain Management in a Dog

Don’t Wait for US Legalization, Here Are 4 Cannabis Stocks to Consider Right Now

With Investors Flocking to Early-Stage Pharma, Here are 4 Stocks to Consider

INNOCAN PHARMA CORPORATION IS UNDERVALUED

With recent expansion into veterinary field, Innocan Pharma (INNO Stock) is primed for major growth

Why this Canadian-Israeli Stock Grew 121% This Year

Innocan Pharma, a leader in the development of innovative CBD delivery methods, has achieved significant goals in 2021

Why Exosomes are a Billion Dollar Market: Innocan Pharma is leading the research

These Five Companies Are Changing the Pharma Industry Through Liposomes

4 CBD Stocks in the Canadian Capital Market

https://www.insidermonkey.com/blog/innocan-pharma-receives-multi-million-dollar-investment-from-american-and-other-institutional-investors-what-does-it-mean-987194/

Innocan Pharma gained 350% in value this year – Is it still a good time to buy?

InnoCan Pharma receives strong buy recommendation: Here is why

From Johnson & Johnson To Israeli Tech Ecosystem

The World's Seven Leading Companies In Exosome Research

Join Iris Bincovich Innocan's CEO and Ron Mayron Innocan's Executive Chairman on LIFE-SAVING-TECHNOLOGIES CONFERENCE 2021 (min 2:47:30)

InnoCan Pharma’s Latest Advisory Board Addition: Israel’s Former Minister Of Science & Technology

This Top Health-Tech Executive joins the CBD Pharma Industry and Boosts Shareholder Confidence

In Response To Potential Cannabis Legalization, Innovative BioTech Prepares For The Future

InnoCan Pharma Launches Trading on OTCQB Venture Market

What is Next for InnoCan Pharma After Strategic Advisory Board Addition

Innocan Pharma’s CEO Iris Bincovich: 'We Are Already Expanding Post-COVID'

3 Biotech Stocks To Watch In 2021

Innocan Pharma closes financing while launching new commercial website shop.innocanpharma.com

watch this interview with Innocan CEO, Iris Bincovich.

How Cannabis-Based Therapeutics By InnoCan Pharma Could Treat COVID-19

InnoCan Pharma Stands With Science To Commercialize CBD

InnoCan Pharma: Ist das der Heilige Gral der Covid-19-Forschung?

VIDEO: Innocan (INNO:CSE) Developing The Pharmaceutical Guided Missile To Defeat Coronavirus Lung Infections

Innocan Pharma strikes deal to distribute its SHIR line of CBD beauty products in Italy and Switzerland

Innocan Pharma teams up with Endless Sky to manufacturer and distribute its CBD products

Innocan Pharma subsidiary inks manufacturing and distribution deal with Calgary cannabis producer Endless Sky

Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has

13 promising Covid treatments emerging from Israel

Cannabis and Coronavirus: As Virus Rates Spike, Industry Continues to Contribute

Cannabis-infused treatment for Covid-19 under development

InnoCan Pharma inks deal securing CBD for its coronavirus treatment collaboration with Tel Aviv University and other R&D projects

Cannabis-infused treatment for Covid-19 under development

Kan English News from 43.30 min

אינוקאן פארמה גייסה 5.1 מיליון דולר קנדי לפיתוח תרופה לקורונה

Innocan raises NIS 12.5 mil to develop CBD-based COVID-19 treatment

Israeli cannabis company InnoCan raises $3.7 million

Innocan Pharma closes $5.1 million financing for CBD drug delivery research

Innocan Pharma launches Derma CBD line in Europe

Full interview: InnoCan Pharma signs deal with ADVA Biotechnology to produce Exosomes with CBD

COVID-19 - A revolutionary treatment approach!

InnoCan Pharma Corp unveils plans to raise up to C$10 million

Israeli scientists begin trials into the effectiveness of cannabis in treating Covid-19

Investigadores israelíes están haciendo pruebas para probar el CBD como tratamiento del COVID-19

Israel Researchers Launch Clinical Trials To Test CBD As COVID-19 Treatment Supplement

Iris Bincovich on "Missile Delivery" of CBD Therapy for the Lungs

Cannabis Companies Join Search For Covid-19 Cure

Innocan Pharma, TAU Ink deal to work on CBD based treatment for covid-19

Iris Bincovich in a podcast with Professionally Cannabis Radio show

InnoCan Pharma planning to develop new line of CBD products and formulations with Tamar Technologies

Full interview: Innocan Pharma plans to collaborate with Tel Aviv University to find treatment for COVID-19

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver to bring news

InnoCan's CEO Iris Bincovich in an interview for the SmallCap Investor TV

TAU to partner with InnoCan Pharma on revolutionary COVID-19 treatment

InnoCan Pharma Corp announces tie-up with Tel Aviv University for new treatment for coronavirus pandemic

Cannabis companies are also seeking a cure for Corona

Will cannabis defeat the Corona? A startup founded by former Teva Israel CEO believes so

Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today

Innocan Pharma CEO Iris Bincovich joined Steve Darling from Proactive Vancouver for a live interview

WHO LAUNCHED THE CANNABIS MENTORS PROGRAM AND WHAT ARE THEY THINKING ABOUT GENDER 19/12/2019

SUN AND SKIN: INNOCAN PHARMA OPENED THE CANADIAN STOCK EXCHANGE CSE MARKET FROM THE BEACH IN TEL AVIV 27/11/19

INNOCAN PHARMA LOOKING TO AT THEIR CBD BY INJECTION TECHNOLOGY AS A GAME CHANGER 4/11/19

FORMER CEO, TEVA ISRAEL HAS ISSUED CANNABIS COMPANY IN CANADA (HEBREW) 26/9/19

INNOCAN LAUNCHES EQUITY FUNDRAISING CAMPAIGN WITH PIPELBIZ

A CANNABIS COMPANY HAS ISSUED STOKES IN CANADA AND ENABLED AN EXIT FOR 522 SMALL INVESTORS

TECHNATION: CANNABIS-BASED DRUGS STARTUP INNOCAN RAISES $830,000 VIA CROWDFUNDING REPORTED IN HAARETZ 28/8/18

INNOCAN RECRUITS 500 INVESTORS ONLINE TO RAISE NIS 3 MILLION AS HIGHLIGHTED IN GLOBES 27/8/18

FIRST SUCCESSFUL INTERNET CAPITAL RAISING IN ISRAEL: INNOCAN IS FEATURED IN THE MARKER (HEBREW) 26/8/18

INNOCAN FEATURED ON THE FINANCIAL NEWS CHANNEL, BIZPORTAL 6/8/18

INNOCAN TV INTERVIEW ON ARUTZ SHEVA 23/7/18

RESHET.TV TALKS ABOUT INNOCAN 11/7/18

INNOCAN FEATURED IN THE GLOBES (ENGLISH) 10/7/18

INNOCAN PUBLISHED IN THE GLOBES (HEBREW) 9/7/18